Bright Minds Biosciences (DRUG) Q4 2025 Earnings — Beat Estimates

Screener

Reported February 12, 2026 · Before market open

EPS-$0.70Beat by $0.28

EPS estimate-$0.98

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q2 2026-$0.17Beat by $1.05 Q1 2026-$0.80Beat by $0.37

Q4 2025-$0.70Beat by $0.28

Q3 2025-$0.41Beat by $0.15 Q1 2025-$0.53Beat by $0.06 Q4 2024$0.01Beat by $0.24

FAQ

When did Bright Minds Biosciences report Q4 2025 earnings?: Bright Minds Biosciences (DRUG) reported Q4 2025 earnings on February 12, 2026 before market open.
What were Bright Minds Biosciences's Q4 2025 revenue and EPS?: Bright Minds Biosciences reported eps of $-0.70 for Q4 2025.
Did Bright Minds Biosciences beat estimates in Q4 2025?: EPS beat the consensus estimate of $-0.98 by $0.28.

Ask the moment Bright Minds Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk